ckd

Documents about ckd

• Hyperuricemia as Early Indication of CKD Progressing in Prediabetic#861712ClinicalTrials.gov
• Multimodal Intervention for Early Chronic Kidney Disease in Young People: Dysbiosis and Inflammation (CKD)#993810ClinicalTrials.gov
• Genetics in the Progression of Nephropathies#471521ClinicalTrials.gov
• Smart-CKD/BP Study#812515ClinicalTrials.gov
• SWE in Assessment of CKD Patients#866621ClinicalTrials.gov
• Prospective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD)#800168ClinicalTrials.gov
• Assesment of Lactulose vs Lactobacillus Acidophilus Effect in CKD Patients#811134ClinicalTrials.gov
• Kidney Awareness Registry and Education#917333ClinicalTrials.gov
• Safety and Efficacy of Canagliflozin in Advanced CKD#982508ClinicalTrials.gov
• A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)#863066ClinicalTrials.gov
• Washed Microbiota Transplantation (WMT) for Chronic Kidney Disease (CKD)#993778ClinicalTrials.gov
• Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)#858789ClinicalTrials.gov
• Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial#801104ClinicalTrials.gov
• Maternal and Fetal Outcome of CKD Mother Patient in Sohag Governorate#911320ClinicalTrials.gov
• CKD-841 Pharmacokinetic/Pharmacodynamic Study#982088ClinicalTrials.gov
• CKD-391 Pharmacokinetic Study Phase I#849108ClinicalTrials.gov
• Uric acid as a biomarker in patients with COPD and CKD#321201ARPHA OAI-PMH Endpoint
• The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4#980547ClinicalTrials.gov
• CKD Awareness, Referrals, Education, and Support Intervention for Early-Stage CKD#633831ClinicalTrials.gov
• Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus#993373ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of CKD-352#850668ClinicalTrials.gov
• CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)#993741ClinicalTrials.gov
• CKD-828 Telmisartan Non-Responder Trial#846723ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of CKD-350#848003ClinicalTrials.gov
• The Design and Conduct of Cohort Studies of Peoples With CKD – International Perspectives From iNET-CKD.#227839NCBI PubMed Central
• Comparative Study Between Oral Liposomal Iron,Iron Supported Lactoferrin and IV Iron Dextran in CKD Children#995503ClinicalTrials.gov
• Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD#353388ClinicalTrials.gov
• Efficacy and Safety of CKD-828 to Stage 2 Hypertension#837094ClinicalTrials.gov
• Very Low Protein Diet and Renal Death in Chronic Kidney Disease (CKD)-ERIKA Study#863255ClinicalTrials.gov
• The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1#889119ClinicalTrials.gov
• A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers#871326ClinicalTrials.gov
• Symptom Assessment And Management For Adults With CKD In Vietnam#881835ClinicalTrials.gov
• Chronic Kidney Disease in Pregnant Females#902465ClinicalTrials.gov
• Meta-organismal tryptophan metabolism: an appealing therapeutic target in CKD-MBD#476031HAL (France)
• Fostering Self-Empowerment in CKD Patients Through Food Choice Mapping#804464ClinicalTrials.gov
• Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)#894840ClinicalTrials.gov
• Gut Microbiome and p-Inulin in CKD - TarGut CKD Study#919031ClinicalTrials.gov
• The Clinical Study to Evaluate Immunogenicity of Epodion® in Anemia Associated With CKD Patients#831383ClinicalTrials.gov
• Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients#887898ClinicalTrials.gov
• CKD-828 (80/5mg) Pharmacokinetic Study#633781ClinicalTrials.gov
• Longitudinal assessment of health-related quality of life in adults with CKD#270326Research Online
• Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKD#288335HAL (France)
• An e-Learning Program for Nurses on Evidence-Based Prevention of CKD#890525ClinicalTrials.gov
• Burden of Chronic Kidney Disease (CKD), Type 2 Diabetes Mellitus (T2DM), and Comorbid T2DM/CKD in Alberta, Canada#991697ClinicalTrials.gov
• Vitamin D Supplementation and Cardiac Hypertrophy in Chronic Kidney Disease (CKD)#992818ClinicalTrials.gov
• Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease#993617ClinicalTrials.gov
• Early Identification and Action in CKD#230526ClinicalTrials.gov
• Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients#813577ClinicalTrials.gov
• Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934#876926ClinicalTrials.gov
• Pharmacokinetics and Safety Profile of CKD-333#158079ClinicalTrials.gov